We develop improved diagnostic testing for conditions related to metabolic dysfunction, including chronic kidney, liver and cardiac diseases.
From a single serum sample, we quantify multiple biomarkers — known and newly discovered. Precision Diagnostics.
Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.
Meeusen JW, Dasari S, Lieske JC, Lemoine S, Derain-Dubourg L, Stämmler F, Schiffer E
Meeusen JW, Dasari S, Lieske JC, Grassi M, Stämmler F, Schiffer E